Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia

A

Ain Shams University

Status

Unknown

Conditions

Pre-Eclampsia

Treatments

Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Study type

Interventional

Funder types

Other

Identifiers

NCT03630276
Shaza Elreweny

Details and patient eligibility

About

Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia

Enrollment

111 estimated patients

Sex

Female

Ages

25 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

- PREECLAMPSIA from 25_45years

Exclusion criteria

chronic diseases Primary hypertension

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

111 participants in 3 patient groups

Neutrophil/lymphocyte ratio
Other group
Treatment:
Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Platelet/lymphocyte ratio
Other group
Treatment:
Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
CRP
Other group
Treatment:
Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems